P53 in kidney injury and repair: Mechanism and therapeutic potentials
Related Experiment Video
Updated: Feb 3, 2026

Mechanical Vessel Injury in Zebrafish Embryos
Published on: February 17, 2015
Chengyuan Tang1, Zhengwei Ma2, Jiefu Zhu1
1Department of Nephrology, Key Laboratory of Kidney Disease and Blood Purification in Hunan, The Second Xiangya Hospital at Central South University, Changsha, Hunan, China.
Abstract:
Acute kidney injury (AKI) is a major kidney disease with poor clinical outcome. Besides its acute consequence of high mortality, AKI may also contribute significantly to the occurrence and progression of chronic kidney diseases (CKD). Accumulating evidence has demonstrated that maladaptive and incomplete kidney repair after AKI leads to the development of renal fibrosis and, ultimately, CKD. p53, a well-known tumor suppressor, plays a critical role in AKI and subsequent kidney repair through the regulation of various cell biologic processes, including apoptosis, cell cycle arrest, and autophagy. Despite the notable progress in deciphering the involvement of p53 in kidney injury and repair, the underlying mechanisms of p53 in these pathological processes remain largely unknown. Further investigation in this area is essential for the application of p53 as therapeutic target to prevent and treat AKI or impede its progression to CKD. In this review, we summarize the recent advances in understanding p53 regulation of AKI and kidney repair, pinpoint the potential of p53 as a therapeutic target, and present future research interests and directions.
Insights
Acute kidney injury (AKI) can lead to chronic kidney disease (CKD) due to incomplete repair. The tumor suppressor p53 influences AKI and repair, offering potential therapeutic targets for preventing CKD progression.
Area of Science:
- Nephrology
- Molecular Biology
- Oncology
Background:
- Acute kidney injury (AKI) is a significant clinical issue with high mortality and contributes to chronic kidney disease (CKD).
- Incomplete kidney repair following AKI is a key factor in the development of renal fibrosis and progression to CKD.
- The tumor suppressor p53 is implicated in AKI and kidney repair processes like apoptosis, cell cycle arrest, and autophagy.
Purpose of the Study:
- To review recent advances in understanding p53's role in AKI and kidney repair.
- To identify the therapeutic potential of p53 in preventing AKI and its progression to CKD.
- To outline future research directions concerning p53 in kidney disease.
Main Methods:
- Literature review of studies investigating p53 in kidney injury and repair.
- Analysis of molecular mechanisms underlying p53's function in renal pathophysiology.
- Synthesis of current knowledge on p53 as a therapeutic target.
Main Results:
- p53 plays a critical role in regulating cellular processes crucial for kidney repair after injury.
- Dysregulation of p53 contributes to maladaptive repair, leading to fibrosis and CKD.
- Understanding p53 mechanisms is vital for developing targeted therapies.
Conclusions:
- p53 is a key regulator in AKI and kidney repair, influencing the transition to CKD.
- Targeting p53 presents a promising strategy for treating AKI and preventing CKD.
- Further research is needed to fully elucidate p53's mechanisms and therapeutic applications in kidney disease.
Related Concept Videos
Acute Kidney Injury I: Introduction
Acute Kidney Injury II: Pathophysiology
Mismatch Repair
Acute Kidney Injury V: Interprofessional Care
Acute Kidney Injury VI: Nursing Management
Overview of DNA Repair
Chemically...

